I received this email this morning from Grandich Publications:

Due to serious illness, Grandich Publications has to suspend operations. For those concerned with Peter Grandich’s well being, we ask for you to pray for his complete healing.

Peter is unable to check email at this time.

I am very sorry to hear this and do pray he may be fully healed and back to work soon. The industry needs honest voices like his.

For those of you who have invested in some stocks he has recommended, I offer you my own observations of a few of them here:

Crosshair Exploration & Mining (CXZ): Crosshair continues to do very well in their business and in their promotion. You can get on their mailing list at their website. The one key fact that they have been trying to shout to the world is that over 90% of their project land lies OUTSIDE the famed Labrador district with its 3 year stupidity policy. I feel that once Canadian Juniors are allowed out of the doghouse this stock should respond quite well. It was one of Peter’s favorites and mine as well.

Geologix (GXEXF, GIX.V): Geologix is doing much better at their business than their promotion, although that’s why they hired Peter, I guess. This is a gold explorer/developer that at least has operations in some friendly territory. I expect good things from this company.

Northern Dynasty Minerals (NAK): This is definitely a Peter Grandich favorite, but a big disappointment in share price. We had been hoping this company would be taken out in the high teens to mid twenties months ago. Now the company can be had for less than when some of the initial excitement started. If it is taken over, we likely will be lucky to get into the teens - for some that will barely break even. Fantastic company, I certainly hope they can boost the share price before negotiating any buyout.

If you are attracted to resource and precious metals stocks like those recommended by Peter Grandich, I think you also might really enjoy the International Speculator from Casey Research. They offer a no risk trial offer.